Toronto-Dominion Bank »

Horizon Therapeutics shares owned by Toronto-Dominion Bank

Quarter-by-quarter ownership of Horizon Therapeutics shares owned by Toronto-Dominion Bank from 13F filings

Historical chart of Toronto-Dominion Bank investment in Horizon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Horizon Therapeutics held by Toronto-Dominion Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Horizon Therapeutics by Toronto-Dominion Bank

Quarter filed Position value Share count Share price at filing
2023-09-30 $42M 360k 115.69
2023-06-30 $73M 708k 102.78
2023-03-31 $23M 185k 121.21
2022-12-31 $22k 191 115.18
2022-09-30 $16k 253 63.24

More positions owned by Toronto-Dominion Bank

Charles Schwab Corporation (SCHW)
Invesco QQQ Trust Series 1 Etf (QQQ)
Rbc Cad (RY)
Apple (AAPL)
Microsoft Corporation (MSFT)
SPDR S&P 500 ETF Trust Etf (SPY)
iShares Russell 2000 ETF Etf (IWM)
Bank Of Montreal Cadcom (BMO)
Cibc Cad (CM)
Bk Nova Cad (BNS)
Tc Energy Corp (TRP)
Tor Dom Bk Cad (TD)
SPDR Gold Shares Etf (GLD)
NVIDIA Corporation (NVDA)
Canadian Natural Resources (CNQ)

View all positions for Toronto-Dominion Bank

Top funds holding Horizon Therapeutics

IFP Advisors
Beacon Capital Management
Huntington National Bank

View all funds holding Horizon Therapeutics